Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma With Portal Vein Thrombosis”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Not applicableWithdrawnNCT01659346
What this trial is testing

Non-selective Beta Blockers Versus EVL for Primary Prophylaxis of Esophageal Variceal Bleeding in Patients With Hepatocellular Carcinoma With Portal Vein Tumour Thrombosis.

Who this might be right for
Hepatocellular Carcinoma With Portal Vein Thrombosis
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)UnknownNCT06040177
What this trial is testing

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma Non-resectablePortal Vein Tumor ThrombusImmune Checkpoint Inhibitors
First Affiliated Hospital of Guangxi Medical University 30
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Not applicableUnknownNCT02813096
What this trial is testing

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

Who this might be right for
Carcinoma, Hepatocellular
Guangxi Medical University 500
Testing effectiveness (Phase 2)Study completedNCT05166239
What this trial is testing

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Peking University 66
Testing effectiveness (Phase 2)UnknownNCT02290977
What this trial is testing

Transarterial Chemoembolization (TACE) With Radiation Therapy (RT) in Advanced Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaPortal Vein Tumor Thrombosis
Samsung Medical Center 40
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Not applicableStudy completedNCT06265883
What this trial is testing

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 205
Post-approval studies (Phase 4)UnknownNCT03178656
What this trial is testing

A Trial to Compare Surgery With Sorafenib for Hepatic Celluler Cancer With Portal Vein Tumor Thrombosis

Who this might be right for
Portal Vein Tumor Thrombus
Huazhong University of Science and Technology 54
Testing effectiveness (Phase 2)UnknownNCT03520257
What this trial is testing

The Study of Apatinib Plus Radiotherapy vs. Apatinib in the Treatment of Hepatocellular Carcinoma With BCLC-C Stage I and Stage II Portal Vein Tumor Thrombus

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 50
Not applicableUnknownNCT05339581
What this trial is testing

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation

Who this might be right for
Liver CancerLiver Transplant; ComplicationsHepatocellular Carcinoma+2 more
RenJi Hospital 78
Large-scale testing (Phase 3)UnknownNCT04387695
What this trial is testing

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Who this might be right for
Unresectable Hepatocellular CarcinomaPortal Vein Thrombosis
First Affiliated Hospital of Zhejiang University 54
Not applicableUnknownNCT05530785
What this trial is testing

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Yongchang Zhang 35
Testing effectiveness (Phase 2)Study completedNCT05625893
What this trial is testing

Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion

Who this might be right for
Hepatocellular CarcinomaPortal Vein Thrombosis
Samsung Medical Center 63
Testing effectiveness (Phase 2)Looking for participantsNCT06031285
What this trial is testing

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 43
Large-scale testing (Phase 3)Active Not RecruitingNCT04649489
What this trial is testing

Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

Who this might be right for
Venous Thrombosis
Jia Fan 501
Testing effectiveness (Phase 2)Looking for participantsNCT06646198
What this trial is testing

TIPS Plus Half-dose Donafenib in AHCC with PVTT-associated Portal Hypertension

Who this might be right for
Hepatocellular Carcinoma with PVTT
Fei Gao 40
Not applicableUnknownNCT02309788
What this trial is testing

Radiotherapy in Hepatocellular Carcinomas After Hepatectomy With Narrow Margin (<1 cm) or Portal Vein Thrombosis

Who this might be right for
HepatoCellular Carcinoma
Guangxi Medical University 100
Testing effectiveness (Phase 2)Looking for participantsNCT05992220
What this trial is testing

Atezolizumab Plus Bevacizumab Alone or Combined with External Beam Radiotherapy for HCC with Macrovascular Invasion

Who this might be right for
Hepatocellular CarcinomaHepatocellular CancerHepatocellular Carcinoma Non-resectable+2 more
Asan Medical Center 138
Post-approval studies (Phase 4)UnknownNCT01350206
What this trial is testing

Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis

Who this might be right for
Hepatocellular Carcinoma With PVTT
Sun Yat-sen University 180
Next Page